Testing ablation treatment for Barrett’s with precancer changes
Part of Cancer, Digestive system clinical trials.
This trial studies whether an “ablation” procedure (destroying abnormal esophagus lining) works well for people with Barrett’s esophagus that has high-grade precancer changes or very early cancer. It may help find safer or more effective ways to prevent the condition from worsening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Barrett’s esophagus with high-grade precancer or very early esophageal adenocarcinoma
- You are a candidate for ablation therapy recommended by your care team
- You can understand the study and sign informed consent
- You can manage daily activities at a level described as performance status 1–2 (not 3–4)
- You are able to tolerate endoscopy procedures (camera tests through the mouth)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at treatment options for people with Barrett’s esophagus that has progressed to abnormal cell growth (dysplasia) or cancer. It may help doctors compare approaches that use procedures to remove and/or destroy abnormal tissue in the esophagus.
This study focuses on people with Barrett’s esophagus who are coming in for an endoscopy check or for treatment of early surface changes. The goal is to better understand these early warning areas and how to manage them safely.
This study looks at people age 18+ who have Barrett’s esophagus and checks for early changes that may lead to cancer. You might qualify if you can consent and are not pregnant.
This study looks at how common certain esophagus lining changes are, what increases risk, and which biopsy sampling method works best. It may help improve how doctors take tissue samples when Barrett’s esophagus is suspected.
This study looks at how Barrett's esophagus affects your quality of life and fear of cancer. It uses new tests to better predict who might develop esophageal cancer, so you can get the right care sooner.
This study looks at how radiofrequency ablation (RFA) affects the flexibility and lining of the esophagus in people with Barrett's esophagus and early cancer. It may help doctors understand how this treatment works.
Hear when a new Barrett's Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.